Research programme: liver disease diagnostic imaging and therapeutics - Takeda Pharmaceutical Company/GE Healthcare
Latest Information Update: 17 Nov 2014
At a glance
- Originator GE Healthcare; Takeda
- Mechanism of Action Image enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Hepatic fibrosis; Liver disorders
Most Recent Events
- 11 Nov 2014 Early research in Liver disorders in Japan & United Kingdom (unspecified route)
- 11 Nov 2014 Early research in Hepatic fibrosis (Diagnosis) in Japan & United Kingdom (unspecified route)